The international Prognostic Index for patients with CLL (CLL-IPI)

At the 20th Congress of the European Hematology Association (EHA), Barbara Eichhorst, MD, of the University of Cologne, Cologne, Germany, discusses a meta-analysis of 26 prognostic factors, including clinical, biological and genetic markers, in patients with chronic lymphocytic leukemia (CLL), for the development of an internationally applicable prognostic index, known as CLL-IPI.

Share this video  
12th June 2015